Quantification of Brain and Kidney Perfusion Before, During, and After Hypothermia Treatment in Neonates With Perinatal Asphyxia Using Contrast-enhanced Ultrasound
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- CEUS Time intensity curves
研究概览
简要总结
In this clinical study vascular dynamics in the neonatal brain and kidney will be monitored by CUES and ULM before, during and after hypothermia treatment in neonates with asphyxia.
详细描述
Perinatal asphyxia (PA) is the reduced supply of oxygen to vital organs during or immediately after birth. PA is one of the most common causes of neonatal mortality in full-term infants worldwide and of hypoxic-ischemic encephalopathy (HIE) with subsequent neurological deficits (spastic cerebral palsy). In addition to brain damage, perinatal asphyxia often leads to dysfunction of other organs. It is not uncommon for this to be accompanied by transient renal failure.
Hypothermia treatment is an established therapeutic measure for neuroprotection in clinical indications of HIE. This involves lowering the core body temperature of affected children to 33.5°C for 72 hours. The therapeutic effect is thought to be due to multifactorial mechanisms, including a reduction in endothelial dysfunction, reduced excretion of free radicals and attenuation of the inflammatory cascade.
In the guidelines for hypothermia treatment in neonatal asphyxia, regular ultrasound examinations are prescribed to clarify damage to the central nervous system (CNS) before, during and after hypothermia treatment.1 In infants, transfontal ultrasound makes it possible to visualize brain structures, vessels and their flow velocities.
The intravenous use of ultrasound contrast enhancers as an aid also opens up the possibility of recording the tissue perfusion of the CNS and kidneys, including the smallest vessels.8 This could provide significantly more information compared to conventional methods and expand our knowledge of the pathophysiology and individual status of tissue perfusion in patients.
For example, two studies at Erlangen University Hospital have successfully used contrast-enhanced ultrasound (CEUS) with the contrast agent known as SonoVue® to visualize postoperative perfusion of the brain after pediatric cardiac surgery.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Fulfillment of the inclusion criteria for hypothermia treatment according to the AWMF guideline
- •Severe acidosis (pH ≤7.0 or a base deficit ≥16 mmol/l) in umbilical cord blood or a blood sample from the first hour of life, and
- •clinical signs of moderate or severe encephalopathy (severity grade 2 or 3 according to Sarnat & Sarnat), and
- •postnatal age ≤6h, and
- •gestational age ≥36 weeks' gestation
- •Consent of the parents/legal guardians
- •Time 1 (before the start of hypothermia treatment)
- •Informing the parents/legal guardians present on site despite an emotionally stressful situation with high individual benefit for the patient
- •If only one parent is present and able to provide information, their consent is sufficient - the second parent is informed repeatedly when they regain the ability to provide information
- •Information adapted to the emergency situation, addressing the personal situation and comprehensible presentation of the plan
- •Time 2 (during hypothermia treatment)
- •->Offer of a further informative discussion/repeated explanation with the parents/legal representatives before the second measurement in order to answer any questions that may have arisen
- •Suitable acoustic window
- •Availability of the qualified examiner
排除标准
- •Lack of consent of at least one parent
- •Pre-existing brain malformations
- •Absence of the competent examiner
结局指标
主要结局
CEUS Time intensity curves
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
All CEUS outcomes will be generated in order to achieve time intensity curves in contrast enhanced ultrasound analysis
CEUS Measurement1
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
PE (Peak-Enhancement)
CEUS Measurement2
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WiAUC (Wash-in Area Under the Curve (AUC(TI: TTP)))
CEUS Measurement3
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WiAUC (Wash-in Area Under the Curve (AUC(TI: TTP)))
CEUS Measurement4
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
RT (Rise Time)
CEUS Measurement5
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
mTT (mean Transit Time local) (mTT-TI))
CEUS Measurement6
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
TTP (Time to Peak)
CEUS Measurement7
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WiR (Wash-in-Rate )
CEUS Measurement8
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WiPI (Wash-in Perfusion Index (WiAUC/RT))
CEUS Measurement9
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WoAUC (Wash-out AUC (AUC(TTP:TO)))
CEUS Measurement10
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WiWoAUC (Wash-in- und Wash-out-AUC (WiAUC+WoAUC))
CEUS Measurement11
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
FT (Fall Time - (TO-TTP))
CEUS Measurement12
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
WOR (Wash-out-Rate) QOF (Quality Of Fit between the echo-power signal and f(t)
CEUS Measurement13
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
QOF (Quality Of Fit between the echo-power signal and f(t)
Near-infrared spectroscopy
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
Near-infrared spectroscopy Non-invasive measurement of oxygen saturation in tissue using a probe that is attached to the head.62 This procedure is already firmly established in the field of pediatric surgery and pediatric cardiology interventions at the University Hospital Erlangen. The probe is attached before the start of the first measurement time point and removed after the end of the third measurement time point. There is no risk of side effects.
Visualization and quantification of cerebral perfusion with CEUS
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
CEUS imaging for cerebral perfusion in asphyxia
Visualization and quantification of of renal perfusion with CEUS
时间窗: before(T1, within the first 6hours of life), during hypothermia treatment(T2, 6-78hours of life), after treatment (T3, within first week of life)
CEUS imaging for renal perfusion in asphyxia
次要结局
- CEUS and NIRS(T1,T2,T3)
- Neurological status assessment (Bayley Score)(Month of life: 3-4 and 6-24)
- MRI imaging in asphyxia(once within first two years of life)
- Comparison of the CEUS time-intensity curve between three timepoints(T1,T2, T3)
- Assessment of blood Lactate(T1, T2, T3)
- EEG signs of seizures(T1 -T3 and through study completion)
- EEG activity(T1 -T3 and through study completion)
- Assessment of renal function GFR(T1 -T3 and through study completion, an average of 3 years)
- Assessment of renal function urea(T1 -T3 and through study completion, an average of 3 years)
- Assessment of renal function urinary status(T1 -T3 and through study completion)
- Assesment of renal function kreatininekinase(T1, T2, T3)
- Assessment of metabolic LDH(T1, T2, T3)
研究者
Ferdinand Knieling
Principal Investigator, Pediatric Translational Imaging Laboratory
University of Erlangen-Nürnberg Medical School
